Northern blots with a MRCKα kinase domain cDNA probe revealed relatively high levels of RNA expression in U937 histiocytic lymphoma, MDA MB 231 breast cancer, A549 lung cancer and PLB 985 myelocytic leukemia cell lines [10]. This evidence concerns the gene CDC42BPA and breast carcinoma.